Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01471
|
|||||
| Drug Name |
AG1478
|
|||||
| Synonyms |
AG-1478; 153436-53-4; Tyrphostin AG 1478; N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine; 175178-82-2; Tyrphostin AG-1478; 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline; AG 1478; AG1478; TYRPHOSTIN; 4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-; UNII-SUH0SEZ9HY; SUH0SEZ9HY; AG-1478 hydrochloride; AG-1478 (Tyrphostin AG-1478); CHEMBL7917; CHEBI:75404; N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine; NSC-693255; AK-63142; N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine; BRD6408; BRD-6408; SR-01000076156; NSC693255
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Nasopharyngeal carcinoma [ICD11: 2B6B] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H14ClN3O2
|
|||||
| Canonical SMILES |
COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Cl)OC
|
|||||
| InChI |
InChI=1S/C16H14ClN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)
|
|||||
| InChIKey |
GFNNBHLJANVSQV-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 153436-53-4
|
|||||
| Pharmaceutical Properties | Molecular Weight | 315.75 | Topological Polar Surface Area | 56.3 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
523974
, 3267095
, 5600223
, 8033257
, 8151403
, 11111880
, 11114011
, 11120225
, 11120713
, 11121201
, 11121455
, 11121935
, 11147308
, 11362524
, 11365086
, 11367648
, 11370319
, 11370320
, 11373249
, 11375810
, 11382272
, 11437777
, 12024897
, 14801206
, 17405683
, 24278735
, 26527902
, 26752149
, 26752150
, 26759702
, 29221232
, 47290912
, 47290913
, 47588775
, 47588776
, 47662031
, 48184767
, 48258972
, 49635532
, 50104794
, 50104795
, 53778233
, 53787589
, 53800470
, 57321117
, 80516749
, 85231256
, 85267415
, 85787241
, 85787738
|
|||||
| ChEBI ID |
CHEBI:75404
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | ||
| References | ||||||
| 1 | EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells. Cancer Lett. 2001 Aug 10;169(1):27-32. | |||||
| 2 | Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. Biochem Pharmacol. 2009 Mar 1;77(5):781-93. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.